Igor A. Mikhailopulo
Impact in
- Physiology top 1%
- Adenosine and Purinergic Signaling
- Infectious Diseases top 5%
- HIV/AIDS drug development and treatment
Papers in
-
- HIV/AIDS drug development and treatment 43
-
- Carbohydrate Chemistry and Synthesis 36
- Co-authors
- Anatoly I. Miroshnikov (17 shared papers)Peter B. Neubauer (6 shared papers)Frank Seela (18 shared papers)Anatolii I Miroshnikov (1 shared paper)Roman Sergeevich Esipov (12 shared papers)Xinrui Zhou (4 shared papers)Erik De Clercq (10 shared papers)Cornelis ALTONA (3 shared papers)
In The Last Decade
Igor A. Mikhailopulo
127 papers receiving 1.5k citations
Peers
Comparison fields: 5 of 79
- Physiology 258
- Infectious Diseases 536
- Pharmaceutical Science 133
- Molecular Biology 1.3k
- Organic Chemistry 476
Countries citing papers authored by Igor A. Mikhailopulo
This map shows the geographic impact of Igor A. Mikhailopulo's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Igor A. Mikhailopulo with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Igor A. Mikhailopulo more than expected).
Fields of papers citing papers by Igor A. Mikhailopulo
This network shows the impact of papers produced by Igor A. Mikhailopulo. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Igor A. Mikhailopulo. The network helps show where Igor A. Mikhailopulo may publish in the future.
Co-authors
The 25 scholars most cited alongside Igor A. Mikhailopulo, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 130 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2011 | 91 | |
| 2 | 2007 | 78 | |
| 3 | 2010 | 65 | |
| 4 | 1991 | 59 | |
| 5 | 2006 | 57 | |
| 6 | New trends in nucleoside biotechnology. | 2010 | 56 |
| 7 | 2013 | 48 | |
| 8 | 2015 | 46 | |
| 9 | 2012 | 38 | |
| 10 | 2008 | 36 | |
| 11 | 2003 | 33 | |
| 12 | 1999 | 32 | |
| 13 | 2002 | 30 | |
| 14 | 1990 | 29 | |
| 15 | 1999 | 27 | |
| 16 | 2014 | 26 | |
| 17 | 2015 | 25 | |
| 18 | 2018 | 24 | |
| 19 | 1979 | 24 | |
| 20 | 2015 | 23 |
About Igor A. Mikhailopulo
Igor A. Mikhailopulo is a scholar working on Infectious Diseases, Organic Chemistry, Molecular Biology, Pharmaceutical Science and Physiology, having authored 130 papers that have together received 1.6k indexed citations. Recurring topics across this work include Biochemical and Molecular Research (69 papers), HIV/AIDS drug development and treatment (43 papers), Carbohydrate Chemistry and Synthesis (36 papers), DNA and Nucleic Acid Chemistry (27 papers), Fluorine in Organic Chemistry (19 papers), Cytomegalovirus and herpesvirus research (14 papers), RNA and protein synthesis mechanisms (10 papers) and Adenosine and Purinergic Signaling (9 papers). The work is most often cited by research in Physiology (258 citations), Infectious Diseases (536 citations), Pharmaceutical Science (133 citations), Molecular Biology (1.3k citations) and Organic Chemistry (476 citations). Igor A. Mikhailopulo has collaborated with scholars based in Belarus, Germany and Russia. Frequent co-authors include Anatoly I. Miroshnikov, Peter B. Neubauer, Frank Seela, Anatolii I Miroshnikov, Roman Sergeevich Esipov, Xinrui Zhou, Erik De Clercq, Cornelis ALTONA, Jan Balzarini and Irina D. Konstantinova. Their work appears in journals such as Nucleosides Nucleotides & Nucleic Acids, Helvetica Chimica Acta, Synthesis, Biotechnology Letters and Synlett.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.